Beck Mack & Oliver LLC Gilead Sciences, Inc. Transaction History

Beck Mack & Oliver LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $749,762 - $854,319	-13,235 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $329,130 - $413,824	-5,300 Reduced 28.59%	13,235 $836,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $2.3 Million - $2.67 Million	-31,791 Reduced 63.17%	18,535 $1.43 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $15.1 Million - $19.3 Million	-240,385 Reduced 82.69%	50,326 $3.76 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $3.3 Million - $3.63 Million	-53,507 Reduced 15.54%	290,711 $18.9 Million
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $1.3 Million - $1.43 Million	-20,772 Reduced 5.69%	344,218 $21.8 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $279,714 - $313,666	-4,521 Reduced 1.22%	364,990 $24.7 Million
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $146,257 - $163,846	-2,339 Reduced 0.63%	369,511 $24 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $1.86 Million - $2.42 Million	-30,642 Reduced 7.61%	371,850 $23.3 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $490,121 - $542,653	6,876 Added 1.74%	402,492 $31.1 Million
Q2 2018 Jul 25, 2018	BUY	$64.88 - $75.68 $786,670 - $917,620	12,125 Added 3.16%	395,616 $0
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $1.51 Million - $1.84 Million	20,703 Added 5.71%	383,491 $0
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $1.34 Million - $1.57 Million	-18,765 Reduced 4.92%	362,788 $0
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $27.5 Million - $32.6 Million	381,553	381,553 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Mack & Oliver LLC with notifications on news.